1991
DOI: 10.1016/0014-4894(91)90147-o
|View full text |Cite
|
Sign up to set email alerts
|

Plasmodium falciparum: Isolation and characterization of a 55-kDa protease with a cathepsin D-like activity from P. falciparum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

1992
1992
2020
2020

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 21 publications
0
9
0
Order By: Relevance
“…Involvement of aspartic proteases in hemoglobin digestion was suspected nearly 50 years ago from the characterization of crude parasite extracts (25,26). The older literature contains numerous reports of hemoglobin-degrading acidic protease activities in various Plasmodium species, and some were shown to be blocked by the canonical aspartic protease inhibitor pepstatin A (25)(26)(27)(28)(29)(30)(31)(32)(33)(34). Their cellular roles remained unclear until studies on isolated digestive vacuoles showed the ability to degrade hemoglobin (16,35), and protease inhibitor profiling of hemoglobinase activity from highly purified digestive vacuoles revealed a central role for aspartic proteases (16).…”
Section: Discoverymentioning
confidence: 99%
See 2 more Smart Citations
“…Involvement of aspartic proteases in hemoglobin digestion was suspected nearly 50 years ago from the characterization of crude parasite extracts (25,26). The older literature contains numerous reports of hemoglobin-degrading acidic protease activities in various Plasmodium species, and some were shown to be blocked by the canonical aspartic protease inhibitor pepstatin A (25)(26)(27)(28)(29)(30)(31)(32)(33)(34). Their cellular roles remained unclear until studies on isolated digestive vacuoles showed the ability to degrade hemoglobin (16,35), and protease inhibitor profiling of hemoglobinase activity from highly purified digestive vacuoles revealed a central role for aspartic proteases (16).…”
Section: Discoverymentioning
confidence: 99%
“…These plasmepsins are capable of forming dimers in crystalline form and in solution (69,70), although it is the monomer that has been shown to be active. The PM III dimer has a loop from one of the subunits that intrudes into the second subunit active site, where it coordinates a zinc ion via Asp 215 and His 32 (67). The canonical Asp 215 -Thr 218 hydrogen bond is disrupted by the zinc coordination.…”
Section: Structure and Mechanismmentioning
confidence: 99%
See 1 more Smart Citation
“…The following antibodies were used: mAb W6/32 (Barnstable et al, 1978), recognizing properly folded human class I complexes; mAb HC10 , specific for human class I free heavy chains (HCs); antihuman HC serum (Stam et al, 1986), specific for free human HCs; antimouse HC serum (Machold et al, 1995), recognizing free HCs only; anti-p8 serum (raised in our laboratory, according to Smith et al [1986], against a synthetic peptide representing the most COOH-terminal exon of the H-2K b molecule); anti-human 132m serum (raised against highly purified [~2 m, separated from HLA-A2 and HLA-A28 by gel filtration in acetic acid); rabbit anti-ER serum provided by Dr. D. Louvard (Institut Pasteur, Paris, France) (Louvard et al, 1982); mouse monoclonal anti-PDI (ID3) provided by Dr. S. Fuller (EMBL, Heidelberg, Germany) (Vaux et al, 1990); rabbit anti-bovine cathepsin D provided by Dr. G. Jaureguiberry (IN-SERM U.13, Hopital Claude Bernard, Paris, France) (Bailly et al, 1991); mouse monoclonal anti-ERGIC 53 provided by Dr. H. P. Hauri (University of Basel, Basel, Switzerland) (Schweizer et al, 1988); rabbit polyclonal affinity purified anti-human ubiquitin and mouse monoclonal anti-E1 provided by Dr. A. Schwartz (Washington University, St. Louis, MO) (Schwartz et al, , 1992. To visualize the primary antibodies nondirectly reactive with protein A, rabbit anti-mouse IgG and rabbit antimouse IgM (Nordic Immunochemicals, Tilburg, The Netherlands) were used.…”
Section: Antibodiesmentioning
confidence: 99%
“…Tu 30 was raised against the Myr 1 amino terminus, and Tu 22 was raised against a synthetic peptide of the Myr 1 tail (Ruppert et al, 1993). We also used polyclonal antibodies directed against rab 5 (Chavrier et al, 1990), polyclonal antibodies directed against the cytoplasmic tail of the lysosomal membrane glycoprotein (lgp 120) (Bakker et al, 1997), monoclonal antibody directed against the Golgi complex (Jasmin et al, 1989), monoclonal antibody directed against rab 7 (Meresse et al, 1995), polyclonal antibodies directed against cathepsin D (Bailly et al, 1991), and monoclonal antibody H68.4 directed against the cytoplasmic tail of transferrin receptor according to White et al (1992). Polyclonal antibodies directed against ␤-actin were a generous gift from C. Chaponnier (Geneva University, Geneva, Switzerland).…”
Section: Antibodiesmentioning
confidence: 99%